Skip to header Skip to main navigation Skip to main content Skip to footer
Home
Academic Citations from Palestine
Foregrounding the Research of Academics in Palestine

Main navigation

  • Home
  • Search
  • About

Pre- and post-COVID-19 antimicrobial resistance profile of bacterial pathogens, a comparative study in a tertiary hospital

Blank
Al-Azhar University – Gaza
Taleb M.H.; Elmanama A.A.; Taleb A.H.; Tawfick M.M.
Taleb, Mohammed H. (57203689573); Elmanama, Abdelraouf A. (8717617200); Taleb, Alaa H. (58304201000); Tawfick, Mahmoud M. (56064207100)
57203689573; 8717617200; 58304201000; 56064207100
2023
Journal of Infection in Developing Countries
Pre- and post-COVID-19 antimicrobial resistance profile of bacterial pathogens, a comparative study in a tertiary hospital
17
5
597
609
Journal of Infection in Developing Countries
Pharmaceutics and Industrial Pharmacy Department, Faculty of Pharmacy, Al-Azhar University-Gaza, Gaza, Palestine; Medical Laboratory Sciences Department, Faculty of Health Sciences, Islamic University of Gaza, Gaza, Palestine; Palestinian Ministry of Health, European Gaza Hospital, Gaza, Palestine; Microbiology and Immunology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt; Microbiology and Immunology Department, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt
Taleb M.H., Pharmaceutics and Industrial Pharmacy Department, Faculty of Pharmacy, Al-Azhar University-Gaza, Gaza, Palestine; Elmanama A.A., Medical Laboratory Sciences Department, Faculty of Health Sciences, Islamic University of Gaza, Gaza, Palestine; Taleb A.H., Palestinian Ministry of Health, European Gaza Hospital, Gaza, Palestine; Tawfick M.M., Microbiology and Immunology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt, Microbiology and Immunology Department, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt
M.M. Tawfick; Faculty of Pharmacy, Al-Azhar University, Cairo, Nasr City, 11751, Egypt; email: mahmoud_tawfick@azhar.edu.eg
19
10.3855/jidc.17791
antimicrobials; bacteria; COVID-19; pandemic; resistance
Anti-Bacterial Agents; Bacteria; COVID-19; Drug Resistance, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Pandemics; Tertiary Care Centers; amikacin; amoxicillin plus clavulanic acid; cefalexin; cefazolin; cefotaxime; ceftazidime; ceftriaxone; cefuroxime; clindamycin; cloxacillin; colistin; cotrimoxazole; doxycycline; erythromycin; gentamicin; meropenem; nalidixic acid; nitrofurantoin; piperacillin plus tazobactam; rifampicin; vancomycin; antiinfective agent; Acinetobacter; antibiotic resistance; antimicrobial stewardship; Article; bacterium; bacterium culture; comparative study; coronavirus disease 2019; disk diffusion; Escherichia coli; female; human; Klebsiella; male; observational study; prevalence; Proteus; Pseudomonas aeruginosa; retrospective study; Staphylococcus aureus; Streptococcus; tertiary care center; antibiotic resistance; bacterium; coronavirus disease 2019; microbial sensitivity test; pandemic